>

Rite Aid Valuation

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>RIT</div>
RAD -- USA Stock  

Earning Report: April 9, 2020  

The current year Free Cash Flow is expected to grow to about 215.7 M, whereas Enterprise Value is expected to decline to about 7.4 B. Rite Aid holds recent Real Value of $13.31 per share. The prevailing price of the company is $15.0. At this time the company appears to be over valued. This module determines value of Rite Aid from analyzing the company fundamentals such as Shares Outstanding of 54.87 M, Return On Equity of 42.83  and Operating Margin of 0.33  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
View Valuation For
Refresh
Rite Aid Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Rite Aid's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Over Valued
Today
15.00
March 31, 2020
13.31
Real Value
38.72
Upside
Rite Aid is very risky asset. Calculation of real value of Rite Aid is based on 3 months time horizon. Increasing Rite Aid time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Rite Aid Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations

Rite Aid Valuation Data Drivers

Rite Aid valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Rite Aid equity instrument and the benefits of owning shares of Rite Aid Corporation. Rite Aid Average Assets are expected to significantly decrease based on the last few years of reporting. The last year's Average Assets were at 6.72 Billion. The current year Earnings before Tax is expected to grow to about 414.5 M, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are expected to decline to about 412.1 M. View More Fundamentals
Average Assets    Earnings Before Interest Taxes and Depreciation Amortization EBITDA    Earnings Before Interest Taxes and Depreciation Amortization USD    

Rite Aid Market Cap

Rite Aid Corporation is rated below average in market capitalization category among related companies. Market capitalization of Pharmaceutical Retailers industry is at this time estimated at about 168.6 Billion. Rite Aid adds roughly 769.89 Million in market capitalization claiming only tiny portion of equities listed under Pharmaceutical Retailers industry.
Capitalization  Revenue  Workforce  Total debt  Valuation
Rite Aid Corporation is rated below average in five year return category among related companies. It is rated below average in price to sales category among related companies fabricating about  0.02  of Price to Sales per Five Year Return. The ratio of Five Year Return to Price to Sales for Rite Aid Corporation is roughly  48.50 

Rite Aid Valuation Basics

Rite Aid Enterprise Value Fundamentals

Quick Ratio0.69
Revenue Growth0.20%
Enterprise Value To Ebitda14.92
Enterprise Value To Revenue0.36

Rite Aid Valuation Indicators

Rite Aid Valuation Fundamental Ratios

Additionally, take a look at Your Equity Center. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page